Gedatolisib plus darolutamide: Early findings in mCRPCByAdam Sharp, PhD, BM, MRCP, BScNovember 17th 2026Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.